Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy-Reference-Cited by-同舟云学术

Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy

Published:2003-09 Issue:2 Volume:140 Page:277-284
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Schaerlinger B,Hickel P,Etienne N,Guesnier L,Maroteaux L

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0705437/fullpdf

Reference40 articles.

1. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation;BERG;J. Pharmacol. Exp. Ther.,2001

2. Molecular biology of 5-HT receptors;BOESS;Neuropharmacology,1994

3. Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y;BRIDDON;Br. J. Pharmacol.,1998

4. The antimigraine drugs ergotamine and dihydroergotamine are potent 5- HT1C receptor agonists in piglet choroid plexus;BROWN;Br. J. Pharmacol.,1991

5. A rapid filtration assay for soluble receptors using polyethylenimine-treated filters;BRUNS;Anal. Biochem.,1983

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited;Journal of Pharmacological and Toxicological Methods;2024-07

2. Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults;Expert Review of Neurotherapeutics;2024-04-24

3. Preclinical Mitigation of 5-Ht2b Agonism-Related Cardiac Valvulopathy Revisited;2024

4. Regulation of Pain Perception by Microbiota in Parkinson Disease;Pharmacological Reviews;2023-10-20

5. Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells;Biochemical Pharmacology;2023-05